Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$51,727,159
+$2,533,106 QoQ
Shares Held
330,061
+2.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#57
of 1,603 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Sep 30, 2025CallValue
$51,296
CallShares
400
PutValue
$89,768
PutShares
700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $2,303,425,127 across 13 Drug Manufacturers - General names. NVS ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,989,537 | $759,252,709 | |
| 2 | ABBV |
AbbVie Inc.
|
2,990,512 | $752,532,439 | |
| 3 | LLY |
ELI LILLY & Co
|
334,637 | $401,373,688 | |
| 4 | AZN |
Astrazeneca PLC
|
841,164 | $159,501,517 | |
| 5 | NVO |
Novo Nordisk A S
|
1,707,104 | $81,838,564 | |
| 6 | NVS |
Novartis AG
This page
|
330,061 | $51,727,159 | |
| 7 | AMGN |
Amgen Inc
|
99,402 | $35,995,452 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
204,677 | $25,858,892 |
All Filings in NVS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,727,159 | 330,061 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $49,194,053 | 322,056 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $95,592,991 | 693,356 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $149,881,397 | 1,168,757 | Shares | Other | 2025-11-13 | |
| 2025-09-30 | $51,296 | 400 | Call | Other | 2025-11-13 | |
| 2025-09-30 | $89,768 | 700 | Put | Other | 2025-11-13 | |
| 2025-06-30 | $173,263,811 | 1,431,814 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $159,725,756 | 1,432,775 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $8,628,088 | 88,666 | Shares | Other | 2025-02-13 | |
| 2024-03-31 | $12,695,522 | 131,247 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $43,651,552 | 432,322 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $107,670,297 | 1,057,042 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $105,179,703 | 1,042,312 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $122,006,352 | 1,326,156 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $73,872,116 | 814,287 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $66,337,043 | 872,741 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $77,573,096 | 917,699 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $59,552,502 | 678,661 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $13,625,463 | 155,773 | Shares | Other | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||